MTOR and neoplasm: They then performed drug screens looking for additional inhibitors that specifically targeted polyploidy tumor cells, and identified that an inhibition of mTOR signaling prevented the formation of therapy-induced polyploidy and maintained the sensitivity of breast cancer cells toward the effects of chemotherapies (148).